Press release content from Business Wire. The AP news staff was not involved in its creation.
Highview Power Closes Growth Capital Funding Round with $70 Million
February 9, 2021 GMT
LONDON & WASHINGTON (BUSINESS WIRE) Feb 9, 2021
Highview Power, a global leader in long duration energy storage solutions, is pleased to announce that it has closed its Growth Capital round of funding with over $70 million, bringing the total amount of funding and grants the company has secured to date to over $145 million. The Growth Capital round includes the previously announced $46 million investment from Sumitomo Heavy Industries (SHI) and additional investments from strategic investors Janus Continental Group (JCG) and TSK, along with a $5.5 million contribution from the original and founding investors.
Press release content from Accesswire. The AP news staff was not involved in its creation.
U.S. Department of Commerce Issues Final Affirmative Countervailing Duty Determinations on Phosphate Fertilizer Imports from Morocco and Russia
February 9, 2021 GMT
TAMPA, FL / ACCESSWIRE / February 9, 2021 / Today, the U.S. Department of Commerce announced its final determination that phosphate fertilizer imports from Morocco and Russia are unfairly subsidized. Commerce calculated a subsidy rate of 19.97 percent for Moroccan producer OCP. In the Russia investigation, Commerce calculated rates of 9.19 percent and 47.05 percent for PhosAgro and EuroChem, respectively, and a rate of 17.2 percent for all other producers/exporters.
The U.S. International Trade Commission (ITC) is conducting a concurrent investigation to determine whether Moroccan and Russian phosphate fertilizer imports materially injure the U.S. phosphate fertilizer industry. A final ruling is expected by mid-March. If the ITC
Press release content from Business Wire. The AP news staff was not involved in its creation.
Positive Preliminary Clinical Trial Results Reported for Vascular Dynamics’ Novel Heart Failure Treatment Technology
February 9, 2021 GMT
IRVINE, Calif. (BUSINESS WIRE) Feb 9, 2021
Vascular Dynamics, Inc., a privately held medical device company focused on innovative, endovascular device-based solutions for cardiovascular conditions, has announced positive preliminary results from its clinical trial, “A Feasibility Study Exploring the Effect of the MobiusHD ® Device in Patients with Heart Failure.”
ADVERTISEMENT
Horst Sievert, MD, Director of the CardioVascular Center in Frankfurt, Germany, and Tamaz Shaburishvili, MD, Head of the Cardiovascular Clinic at Tbilisi Heart and Vascular Clinic in Tbilisi, Georgia, shared preliminary results of the clinical trial as part of a CSI Focus D-HF webinar presented last week.